SCHEMBL14798802

SCHEMBL14798802

CC(C)(C)OC(=O)N(Cc1ccc(NC(=O)Oc2ccccc2)cc1F)S(N)(=O)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAD51 Q06609 2/20 0.48
▸ POLB P06746 2/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ MAPT P10636 5/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ THRB P10828 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ CYP1A2 P05177 2/20 0.39
▸ CYP2D6 P10635 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ ATM Q13315 1/20 0.37
▸ GAA P10253 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28370608 0.84 ALDH1A1 (0.47) RAD51ALDH1A1MAPTKDM4EMEN1
SCHEMBL14951118 0.78 RAD51 (0.49) RAD51POLBALDH1A1MAPTKDM4E
SCHEMBL28813280 0.77 RIPK1 (0.36) —
SCHEMBL14798800 0.77 CA12 (0.55) RAD51POLBALDH1A1MAPTKDM4E
SCHEMBL13631365 0.74 RAD51 (0.47) RAD51POLBALDH1A1MAPTKDM4E
SCHEMBL12984084 0.73 RAD51 (0.57) RAD51POLBALDH1A1MAPTKDM4E
SCHEMBL13194428 0.73 RAD51 (0.54) RAD51POLBALDH1A1MAPTKDM4E
SCHEMBL12982572 0.73 RAD51 (0.55) RAD51POLBALDH1A1MAPTKDM4E
SCHEMBL8233776 0.73 RAD51 (0.47) RAD51POLBALDH1A1MAPTKDM4E
SCHEMBL3866101 0.72 RAD51 (0.46) RAD51POLBALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8937092-B2 Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands GRUENENTHAL GMBH (DE) 2015-01-20 — — US disclosed
EP-2760835-A1 ARYL OR N-HETEROARYL SUBSTITUTED METHANESULFONAMIDE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS Grünenthal GmbH (DE) 2014-08-06 — — EP disclosed
WO-2013045447-A1 ARYL OR N-HETEROARYL SUBSTITUTED METHANESULFONAMIDE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS Grünenthal GmbH (DE) 2013-04-04 — — WO disclosed
US-20130079377-A1 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands GRUENENTHAL GMBH (DE) 2013-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079377-A1 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands TRPV1, TRPV3, TRPA1 RAD51 4592/4885POLB 4744/4885ALDH1A1 2770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback